Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry?

about

Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry?

Item

http://www.wikidata.org/entity/Q57245381

description

im März 2016 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2016

@uk

name

Cervical cancer risk with the ...... tis: to worry or not to worry?

@en

Cervical cancer risk with the ...... tis: to worry or not to worry?

@nl

type

Item

label

Cervical cancer risk with the ...... tis: to worry or not to worry?

@en

Cervical cancer risk with the ...... tis: to worry or not to worry?

@nl

prefLabel

Cervical cancer risk with the ...... tis: to worry or not to worry?

@en

Cervical cancer risk with the ...... tis: to worry or not to worry?

@nl

P1476

Cervical cancer risk with the ...... tis: to worry or not to worry?

@en

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.

Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County.

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.

Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden.

P304

1265-1267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/ANNRHEUMDIS-2015-208526

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jasvinder A. Singh

P577

2016-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26951640

http://www.w3.org/2001/XMLSchema#string

P921

TNF